Engagement in human immunodeficiency virus care: Linkage, retention, and antiretroviral therapy adherence

Infectious Disease Clinics of North America

Volumn 28, Issue 3, 2014, Pages 355-369

  Eaton, Ellen F ^a   Saag, Michael S ^a   Mugavero, Michael ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adherence monitoring; Human immunodeficiency virus retention; Linkage to care

Indexed keywords

DIDANOSINE; LAMIVUDINE; STAVUDINE; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

CAREGIVER; CASE MANAGEMENT; CD4 LYMPHOCYTE COUNT; COGNITIVE THERAPY; DEPRESSION; DISEASE CONTROL; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG MONITORING; EVIDENCE BASED MEDICINE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSTITUTIONALIZATION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT COUNSELING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUBSTANCE USE; BEHAVIOR THERAPY; FOLLOW UP; HIV INFECTIONS; MEDICATION COMPLIANCE; PROCEDURES;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BEHAVIOR THERAPY; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; MEDICATION ADHERENCE;

EID: 84906267030     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2014.06.004     Document Type: Review

References (56)

1. Hogg R.S., Heath K.V., Yip B., et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998, 279(6):450-454. PubMed PMID: 9466638.
2. Centers for Disease Control and Prevention. HIV surveillance report, 2009, vol. 21. 2011. Available at:. Accessed December 21, 2011. http://www.cdc.gov/hiv/surveillance/resources/reports/2009report.
3. Tripathi A., Youmans E., Gibson J.J., et al. The impact of retention in early HIV medical care on viro-immunological parameters and survival: a statewide study. AIDS Res Hum Retroviruses 2011, 27:751-758.
4. Cohen M.S., Chen Y.Q., McCauley M., HPTN 052 Study Team, et al. Prevention of HIV-1 infection with early antiretroviral therapy. NEngl J Med 2011, 365:493-505.
5. Lesko C.R., Cole S.R., Poole C., et al. Asystematic review and meta-regression oftemporal trends in adult CD4+ cell count at presentation to HIV care, 1992-2011. Clin Infect Dis 2013, 57(7):1027-1037.
6. McManus H., O'Connor C.C., Boyd M., Australian HIV Observational Database, et al. Long-term survival in HIV positive patients with up to 15 years of antiretroviral therapy. PLoS One 2012, 7(11):e48839. 10.1371/journal.pone.0048839.
7. Quinn T.C., Wawer M.J., Sewankambo N., et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. NEngl J Med 2000, 342(13):921-929.
8. Giordano T.P., Gifford A.L., White A.C., et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis 2007, 44(11):1493-1499.
9. Mugavero M.J., Amico K.R., Westfall A.O., et al. Early retention in care and viral load suppression: implications for a test and treat approach to HIV prevention. JAcquir Immune Defic Syndr 2012, 58:86-93.
10. Mugavero M.J., Lin H.Y., Willig J.W., et al. Missed visits and mortality in patients establishing initial outpatient HIV treatment. Clin Infect Dis 2009, 48:248-256.
11. Giordano T.P., White A.C., Sajja P., et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. JAcquir Immune Defic Syndr 2003, 32:399-405.
12. Thompson M.A., Mugavero M.J., Amico K.R., et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med 2012, 156(11):817-833. W-284-94. 10.7326/0003-4819-156-11-201206050-00419.
13. Zetola N.M., Bernstein K., Ahrens K., et al. Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007. BMC Public Health 2009, 9:17.
14. Sweeney P., Gardner L.I., Buchacz K., et al. Shifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection. Milbank Q 2013, 91(3):558-603.
15. Mugavero M.J., Davila J.A., Nevin C.R., et al. From access to engagement: measuring retention in outpatient HIV clinical care. AIDS Patient Care STDS 2010, 24:607-613.
16. Gardner L.I., Metsch L.R., Anderson-Mahoney P., Antiretroviral Treatment and Access Study Group, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS 2005, 19:423-431.
17. Naar-King S., Bradford J., Coleman S., et al. Retention in care of persons newly diagnosed with HIV: outcomes of the outreach initiative. AIDS Patient Care STDS 2007, 21(Suppl 1):S40-S48.
18. Bradford J.B., Coleman S., Cunningham W. HIV system navigation: an emerging model to improve HIV care access. AIDS Patient Care STDS 2007, 21(Suppl 1):S49-S58.
19. Gardner L., Marks G., Craw J., et al. Alow-effort clinic-wide intervention improves attendance for HIV primary care. Clin Infect Dis 2012, 55:1124-1134.
20. Gardner L.I., Giordano T.P., Marks G., For the Retention in Care Study Group, et al. Enhanced personal contact with HIV patients improves retention in primary care: a randomized trial in six US HIV clinics. Clin Infect Dis 2014, [Epub ahead of print].
21. Nachega J.B., Parienti J.J., Uthman O.A., et al. Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: a meta-analysis of randomized controlled trials. Clin Infect Dis 2014, 58:1297-1307.
22. Flexner C., Tierney C., Gross R., ACTG A5073 Study Team, et al. Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. Clin Infect Dis 2010, 50:1041-1052.
23. Molina J.M., Podsadecki T.J., Johnson M.A., et al. Alopinavir/ritonavir-based once-daily regimen results in better compliance and is non-inferior to a twice-daily regimen through 96 weeks. AIDS Res Hum Retroviruses 2007, 23:1505-1514.
24. Gardner E.M., Sharma S., Peng G., et al. Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS 2008, 22(1):75-82.
25. Petersen M.L., Wang Y., van der Laan M.J., et al. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis 2007, 45:908-915.
26. Pop-Eleches C., Thirumurthy H., Habyarimana J.P., et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS 2011, 25:825-834.
27. de Bruin M., Hospers H.J., van Breukelen G.J., et al. Electronic monitoring-based counseling to enhance adherence among HIV-infected patients: a randomized controlled trial. Health Psychol 2010, 29:421-428.
28. Sabin L.L., DeSilva M.B., Hamer D.H., et al. Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China. AIDS Behav 2010, 14:580-589.
29. Tuldrà A., Fumaz C.R., Ferrer M.J., et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. JAcquir Immune Defic Syndr 2000, 25:221-228.
30. Collier A.C., Ribaudo H., Mukherjee A.L., et al. Adult AIDS Clinical Trials Group 746 Substudy Team. A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy. JInfect Dis 2005, 192:1398-1406.
31. Reynolds N.R., Testa M.A., Su M., AIDS Clinical Trials Group 731 and 384 Teams, et al. Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. JAcquir Immune Defic Syndr 2008, 47:62-68.
32. Williams A.B., Fennie K.P., Bova C.A., et al. Home visits to improve adherence tohighly active antiretroviral therapy: a randomized controlled trial. JAcquir Immune Defic Syndr 2006, 42:314-321.
33. Antoni M.H., Carrico A.W., Durán R.E., et al. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med 2006, 68:143-151.
34. Frick P., Tapia K., Grant P., et al. The effect of a multidisciplinary program on HAART adherence. AIDS Patient Care STDS 2006, 20:511-524.
35. Levy R.W., Rayner C.R., Fairley C.K., Melbourne Adherence Group, et al. Multidisciplinary HIV adherence intervention: a randomized study. AIDS Patient Care STDS 2004, 18:728-735.
36. Wolitski R.J., Kidder D.P., Pals S.L., Housing and Health Study Team, et al. Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. AIDS Behav 2010, 14:493-503.
37. Andersen M., Hockman E., Smereck G., et al. Retaining women in HIV medical care. JAssoc Nurses AIDS Care 2007, 18:33-41.
38. Hirsch J.D., Rosenquist A., Best B.M., et al. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries. JManag Care Pharm 2009, 15:32-41.
39. Branson B.M., Handsfield H.H., Lampe M.A., Centers for Disease Control and Prevention (CDC), et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006, 55(RR-14):1-17.
40. Stringer J.S., Sinkala M., Stout J.P., et al. Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings. JAcquir Immune Defic Syndr 2003, 32:506-513.
41. Megazzini K.M., Sinkala M., Vermund S.H., et al. Acluster-randomized trial of enhanced labor ward-based PMTCT services to increase nevirapine coverage in Lusaka, Zambia. AIDS 2010, 24:447-455.
42. Altice F.L., Kamarulzaman A., Soriano V.V., et al. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 2010, 376:367-387.
43. Lucas G.M., Chaudhry A., Hsu J., et al. Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: a randomized trial. Ann Intern Med 2010, 152:704-711.
44. Berg K.M., Litwin A., Li X., et al. Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial. Drug Alcohol Depend 2011, 113:192-199.
45. Conway B., Prasad J., Reynolds R., et al. Directly observed therapy for the management of HIV-infected patients in a methadone program. Clin Infect Dis 2004, 38(Suppl 5):S402-S408.
46. Gonzalez J.S., Batchelder A.W., Psaros C., et al. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. JAcquir Immune Defic Syndr 2011, 58:181-187.
47. Safren S.A., O'Cleirigh C., Tan J.Y., et al. Arandomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol 2009, 28:1-10.
48. Berger S., Schad T., von Wyl V., et al. Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons. AIDS 2008, 22:767-775.
49. Mostashari F., Riley E., Selwyn P.A., et al. Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. JAcquir Immune Defic Syndr Hum Retrovirol 1998, 18:341-348.
50. Moss A.R., Hahn J.A., Perry S., et al. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis 2004, 39:1190-1198.
51. Kushel M.B., Colfax G., Ragland K., et al. Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection. Clin Infect Dis 2006, 43:234-242.
52. Ryscavage P., Anderson E.J., Sutton S.H., et al. Clinical outcomes of adolescents and young adults in adult HIV care. JAcquir Immune Defic Syndr 2011, 58:193-197.
53. Ellis D.A., Naar-King S., Cunningham P.B., et al. Use of multisystemic therapy to improve antiretroviral adherence and health outcomes in HIV-infected pediatric patients: evaluation of a pilot program. AIDS Patient Care STDS 2006, 20:112-121.
54. Garvie P.A., Lensing S., Rai S.N. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS. Pediatrics 2007, 119:893-899.
55. Myung P., Pugatch D., Brady M.F., et al. Directly observed highly active antiretroviral therapy for HIV-infected children in Cambodia. Am J Public Health 2007, 97:974-977.
56. Wohl A.R., Garland W.H., Wu J., et al. Ayouth-focused case management intervention to engage and retain young gay men of color in HIV care. AIDS Care 2011, 23:988-997.